Zhang et al. showed that samples with high tumor microenvironment (TME) scores were characterized by immune activation, TGF pathway activation, and high expression of immune checkpoint genes, while those with low TME scores were characterized by a high-frequency of IDH1 and MET mutations27. The gene discussed is IDH1; the disease is neoplasm.